Skip to content

Non-invasive Near-infrared Spectroscopy (NIRS) Versus Invasive Licox Intracranial Pressure

Non-invasive Near-infrared Spectroscopy (NIRS) Versus Invasive Licox Intracranial Pressure Monitoring in Neurocritical Care

Status
Withdrawn
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04247321
Enrollment
0
Registered
2020-01-30
Start date
2021-09-01
Completion date
2023-06-01
Last updated
2021-10-05

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Brain Injuries

Brief summary

Researchers are trying to assess how accurately and safely NIRS non-invasive monitoring can detect changes in intracranial pressure to determine if this noninvasive device can be used instead of invasive monitoring with Licox in the future.

Interventions

DEVICELicox® Brain Tissue Oxygen Monitoring System

Invasive brain tissue oxygenation monitoring

Non-invasive approach to monitoring brain tissue oxygenation which uses two wavelengths of near infrared light and takes measurements of the ratio of oxyhemoglobin to total hemoglobin

Sponsors

Mayo Clinic
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
DEVICE_FEASIBILITY
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

Inclusion: * Subjects with acute brain injury who are age ≥ 18 * Glasgow coma scale score (GCS) ≤ 8 * Neuroimaging concerning for ICP crises, or have active ICP treatment * Have Licox Brain Tissue Oxygen monitor placed as standard of care treatment Exclusion: * CNS infection * Bleeding diathesis or thrombocytopenia \< 50,000 platelets * Subjects with subdural hematomas who have had surgical decompression and bone flap removal

Design outcomes

Primary

MeasureTime frameDescription
Correlation between changes in Licox and NIRS oxygenation measurements3 to 5 days of the monitoring durationLicox measures oxygenation in terms of partial pressure (PtO2) and NIRS measures it in terms of saturation (rSO2). The changes in PtO2 versus the changes in rSO2 will be compared for equivalence.

Secondary

MeasureTime frameDescription
Correlation between changes in pressure reactivity index and Licox versus NIRS3 to 5 days of the monitoring durationThe pressure reactivity index (PRx) is derived using ICM+ software; the PRx is a correlation coefficient ranging from -1 to +1; PRx \> 0 indicates poor autoregulation. We will investigate if PRx correlates with changes in rSO2 as measured by NIRS (if changes in autoregulation correspond with changes in oxygenation).

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 25, 2026